INTERNATIONAL PATENT: PB IMMUNE THERAPEUTICS, INC, 주식회사 피비이뮨테라퓨틱스, SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION, 서울대학교산학협력단 FILES APPLICATION FOR "ANTAGONISTIC ANTI-CD40 HUMANIZED ANTIBODY"

Posted On: 2026-01-13

GENEVA, Jan. 13 -- PB IMMUNE THERAPEUTICS, INC ((Dongsung-dong, SNUCM GLOBAL CENTER) 230ho, 71 Ihwajang-gilJongno-guSeoul 03087), 주식회사 피비이뮨테라퓨틱스 (서울특별시종로구이화장길 71, 230호(동숭동, 서울대학교 의과대학 국제관)), SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (1 Gwanak-roGwanak-guSeoul 08826), 서울대학교산학협력단 (서울특별시관악구관악로 1) filed a patent applic...

Click here to read full article from source

इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया हमे संपर्क करें.

विशेष

Category

Source

Publication

Location

INTERNATIONAL PATENT: PB IMMUNE THERAPEUTICS, INC, 주식회사 피비이뮨테라퓨틱스, SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION, 서울대학교산학협력단 FILES APPLICATION FOR "ANTAGONISTIC ANTI-CD40 HUMANIZED ANTIBODY"